Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Rarity Bioscience Raises Additional €500,000
The Swedish molecular diagnostics startup raised the additional money as part of an oversubscription of an earlier €2.5 million seed financing round.
Genetic Technologies to Raise A$5M in Direct Stock Offering
The firm said several institutional investors had inked definitive agreements for the purchase and sale of 3,846,155 American Depositary Shares.
MDxHealth Prices $40M Public Offering
The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.
Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug
The companies will jointly develop and commercialize Guardant360 CDx and Guardant360 TissueNext for taletrectinib treatment in advanced and metastatic NSCLC.
The firm plans to present data from a large validation study of the Signal-C early detection test later this year as it contemplates approval.